A citation-based method for searching scientific literature


List of co-cited articles
15 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Schizophrenia risk from complex variation of complement component 4.
Aswin Sekar, Allison R Bialas, Heather de Rivera, Avery Davis, Timothy R Hammond, Nolan Kamitaki, Katherine Tooley, Jessy Presumey, Matthew Baum, Vanessa Van Doren,[...]. Nature 2016
37

Effects of inflammation on the kynurenine pathway in schizophrenia - a systematic review.
Bruno Pedraz-Petrozzi, Osama Elyamany, Christoph Rummel, Christoph Mulert. J Neuroinflammation 2020
18
25

Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update.
Iris E Sommer, Roos van Westrhenen, Marieke J H Begemann, Lot D de Witte, Stefan Leucht, René S Kahn. Schizophr Bull 2014
188
25

Dopamine, psychosis and schizophrenia: the widening gap between basic and clinical neuroscience.
J P Kesby, D W Eyles, J J McGrath, J G Scott. Transl Psychiatry 2018
87
25


Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
J H Krystal, L P Karper, J P Seibyl, G K Freeman, R Delaney, J D Bremner, G R Heninger, M B Bowers, D S Charney. Arch Gen Psychiatry 1994
25

Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review.
Susana Ochoa, Judith Usall, Jesús Cobo, Xavier Labad, Jayashri Kulkarni. Schizophr Res Treatment 2012
267
25

Common polygenic variation contributes to risk of schizophrenia and bipolar disorder.
Shaun M Purcell, Naomi R Wray, Jennifer L Stone, Peter M Visscher, Michael C O'Donovan, Patrick F Sullivan, Pamela Sklar. Nature 2009
25


Inflammatory biomarkers in psychosis and clinical high risk populations.
Shannon Delaney, Brian Fallon, Armin Alaedini, Robert Yolken, Alyssa Indart, Tianshu Feng, Yuanjia Wang, Daniel Javitt. Schizophr Res 2019
11
25

Cytokines, Oxidative Stress and Cellular Markers of Inflammation in Schizophrenia.
Rachel Upthegrove, Golam M Khandaker. Curr Top Behav Neurosci 2020
32
25

Oxidative Stress and Inflammation in First-Episode Psychosis: A Systematic Review and Meta-analysis.
David Fraguas, Covadonga M Díaz-Caneja, Miriam Ayora, Fabián Hernández-Álvarez, Alberto Rodríguez-Quiroga, Sandra Recio, Juan C Leza, Celso Arango. Schizophr Bull 2019
45
25



Cholinergic abnormalities in autism: is there a rationale for selective nicotinic agonist interventions?
Stephen I Deutsch, Maria R Urbano, Serina A Neumann, Jessica A Burket, Elionora Katz. Clin Neuropharmacol 2010
54
12

Serotonergic system, cognition, and BPSD in Alzheimer's disease.
Saikat Chakraborty, Jack C Lennon, Sridhar A Malkaram, Yan Zeng, Daniel W Fisher, Hongxin Dong. Neurosci Lett 2019
21
12

Alzheimer's Disease and Autistic Spectrum Disorder: Is there any Association?
Sarah A Khan, Shahida A Khan, A R Narendra, Gohar Mushtaq, Solafa A Zahran, Shahzad Khan, Mohammad A Kamal. CNS Neurol Disord Drug Targets 2016
7
14

Histamine Regulates the Inflammatory Profile of SOD1-G93A Microglia and the Histaminergic System Is Dysregulated in Amyotrophic Lateral Sclerosis.
Savina Apolloni, Paola Fabbrizio, Susanna Amadio, Giulia Napoli, Veronica Verdile, Giovanna Morello, Rosario Iemmolo, Eleonora Aronica, Sebastiano Cavallaro, Cinzia Volonté. Front Immunol 2017
21
12

Analysis of CHRNA7 rare variants in autism spectrum disorder susceptibility.
Elena Bacchelli, Agatino Battaglia, Cinzia Cameli, Silvia Lomartire, Raffaella Tancredi, Susanne Thomson, James S Sutcliffe, Elena Maestrini. Am J Med Genet A 2015
27
12


Neuroimmune Alterations in Autism: A Translational Analysis Focusing on the Animal Model of Autism Induced by Prenatal Exposure to Valproic Acid.
Iohanna Deckmann, Gustavo Brum Schwingel, Mellanie Fontes-Dutra, Victorio Bambini-Junior, Carmem Gottfried. Neuroimmunomodulation 2018
20
12

Autism.
Meng-Chuan Lai, Michael V Lombardo, Simon Baron-Cohen. Lancet 2014
911
12

The cerebellum, sensitive periods, and autism.
Samuel S-H Wang, Alexander D Kloth, Aleksandra Badura. Neuron 2014
310
12

Histamine: a new immunomodulatory player in the neuron-glia crosstalk.
Sandra M Rocha, Joel Pires, Marta Esteves, Baltazar Graça, Liliana Bernardino. Front Cell Neurosci 2014
47
12

Copy number variation in schizophrenia in the Japanese population.
Masashi Ikeda, Branko Aleksic, George Kirov, Yoko Kinoshita, Yoshio Yamanouchi, Tsuyoshi Kitajima, Kunihiro Kawashima, Tomo Okochi, Taro Kishi, Irina Zaharieva,[...]. Biol Psychiatry 2010
89
12

Prevalence of Autism Spectrum Disorder Among US Children and Adolescents, 2014-2016.
Guifeng Xu, Lane Strathearn, Buyun Liu, Wei Bao. JAMA 2018
123
12

Histaminergic system in brain disorders: lessons from the translational approach and future perspectives.
Diego Baronio, Taylor Gonchoroski, Kamila Castro, Geancarlo Zanatta, Carmem Gottfried, Rudimar Riesgo. Ann Gen Psychiatry 2014
25
12

[The behavioral and psychological symptoms of dementia in down syndrome (BPSD-DS) scale: comprehensive assessment of psychopathology in down syndrome].
Alain D Dekker, Yannick Vermeiren, Gonny Beugelsdijk, Mieke Schippers, Lyanne Hassefras, José Eleveld, Sharina Grefelman, Roelie Fopma, Monique Bomer-Veenboer, G Danielle E Oosterling,[...]. Tijdschr Gerontol Geriatr 2018
2
50

Association between microdeletion and microduplication at 16p11.2 and autism.
Lauren A Weiss, Yiping Shen, Joshua M Korn, Dan E Arking, David T Miller, Ragnheidur Fossdal, Evald Saemundsen, Hreinn Stefansson, Manuel A R Ferreira, Todd Green,[...]. N Engl J Med 2008
12

Brain histamine and schizophrenia: potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649.
Xavier Ligneau, Laurent Landais, David Perrin, Johanne Piriou, Marilyne Uguen, Emmanuel Denis, Philippe Robert, Régis Parmentier, Christelle Anaclet, Jian-Sheng Lin,[...]. Biochem Pharmacol 2007
85
12

Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
S Akhondzadeh, S Erfani, M R Mohammadi, M Tehrani-Doost, H Amini, S S Gudarzi, M T Yasamy. J Clin Pharm Ther 2004
29
12

SHANK1 Deletions in Males with Autism Spectrum Disorder.
Daisuke Sato, Anath C Lionel, Claire S Leblond, Aparna Prasad, Dalila Pinto, Susan Walker, Irene O'Connor, Carolyn Russell, Irene E Drmic, Fadi F Hamdan,[...]. Am J Hum Genet 2012
205
12

Genetic heritability and shared environmental factors among twin pairs with autism.
Joachim Hallmayer, Sue Cleveland, Andrea Torres, Jennifer Phillips, Brianne Cohen, Tiffany Torigoe, Janet Miller, Angie Fedele, Jack Collins, Karen Smith,[...]. Arch Gen Psychiatry 2011
979
12

Randomized clinical study of a histamine H3 receptor antagonist for the treatment of adults with attention-deficit hyperactivity disorder.
Richard H Weisler, Gahan J Pandina, Ella J Daly, Kimberly Cooper, Cristiana Gassmann-Mayer. CNS Drugs 2012
57
12

Famotidine has a neuroprotective effect on MK-801 induced toxicity via the Akt/GSK-3β/β-catenin signaling pathway in the SH-SY5Y cell line.
Gokhan Unal, Alim Hüseyin Dokumaci, Ceren Sahin Ozkartal, Mukerrem Betul Yerer, Feyza Aricioglu. Chem Biol Interact 2019
3
33

Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome.
Gregory P Strauss, William P Horan, Brian Kirkpatrick, Bernard A Fischer, William R Keller, Pinar Miski, Robert W Buchanan, Michael F Green, William T Carpenter. J Psychiatr Res 2013
210
12

Anticonvulsant and procognitive properties of the non-imidazole histamine H3 receptor antagonist DL77 in male adult rats.
Bassem Sadek, Ali Saad, Dhanasekaran Subramanian, Mohamed Shafiullah, Dorota Łażewska, Katarzyna Kieć-Kononowiczc. Neuropharmacology 2016
41
12

The genetics of autism.
Rebecca Muhle, Stephanie V Trentacoste, Isabelle Rapin. Pediatrics 2004
637
12

Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review.
Stéphane Potvin, Emmanuel Stip, Amir A Sepehry, Alain Gendron, Ramatoulaye Bah, Edouard Kouassi. Biol Psychiatry 2008
675
12



Animal models of neuropsychiatric disorders.
Eric J Nestler, Steven E Hyman. Nat Neurosci 2010
12

Glutamatergic and GABAergic gene sets in attention-deficit/hyperactivity disorder: association to overlapping traits in ADHD and autism.
J Naaijen, J Bralten, G Poelmans, J C Glennon, B Franke, J K Buitelaar. Transl Psychiatry 2017
39
12

Neuroglial activation and neuroinflammation in the brain of patients with autism.
Diana L Vargas, Caterina Nascimbene, Chitra Krishnan, Andrew W Zimmerman, Carlos A Pardo. Ann Neurol 2005
12

Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial.
Ali Ghaleiha, Mohammad Ghyasvand, Mohammad-Reza Mohammadi, Mehdi Farokhnia, Noorollah Yadegari, Mina Tabrizi, Reza Hajiaghaee, Habibeh Yekehtaz, Shahin Akhondzadeh. J Psychopharmacol 2014
40
12



Ciproxifan, an H3 receptor antagonist, alleviates hyperactivity and cognitive deficits in the APP Tg2576 mouse model of Alzheimer's disease.
Mark E Bardgett, Natasha N Davis, Patrick J Schultheis, Molly S Griffith. Neurobiol Learn Mem 2011
47
12



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.